How Phase I CROs Can Meet Expectations By Understanding Drug Sponsor Needs

Gain insight into how ISR’s Phase I Market Outlook report can help clinical operations professionals at contract research organizations understand their clients' current and future needs, which qualities are most desired in a CRO, and how top criteria differ between simple and complex Phase I studies.

Current and predicted study spending and outsourcing proportions are key pieces of information that drug sponsors and service providers should be familiar with, and the Phase I Market Outlook report aims to address that need. Download the article to learn more.